Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies

SIMPLE SUMMARY: Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the second most common cause of cancer-related mortality worldwide. Currently available targeted therapies for metastatic CRC mainly target vascular endothelial growth factor and epidermal growth factor recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nannan, Cao, Yuepeng, Si, Chengshuai, Shao, Peng, Su, Guoqing, Wang, Ke, Bao, Jun, Yang, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600272/
https://www.ncbi.nlm.nih.gov/pubmed/36291943
http://dx.doi.org/10.3390/cancers14205160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600272/
https://www.ncbi.nlm.nih.gov/pubmed/36291943
http://dx.doi.org/10.3390/cancers14205160

Ejemplares similares